References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Stosic-Grujicicetal(2007)Apotentimmunomodulatorycompound(S,R)-3-phenyl-4,5-dihydro-5-isoxasoleaceticacid,preventsspontaneousandacceleratedformsofautoimmunediabetesinNODmiceandinhibitstheimmunoinflammatorydiabetesinducedbymultiplelowdosesofstreJ.Pharmacol.Exp.Ther.3201038PMID:17148780
Stojanovicetal(2007)Invitro,exvivoandinvivoimmunopharmacologicalactivitiesoftheisoxazolinecompoundVGX-1027:Modulationofcytokinesynthesisandpreventionofbothorgan-specificandsystemicautoimmunediseasesinmurinemodels.Clin.Immunol.123311PMID:17449326
Manganoetal(2008)Invitroinhibitionofenterobacteria-reactiveCD4+CD25-TcellsandsuppressionofimmunoinflammatorycolitisinmicebythenovelimmunomodulatoryagentVGX-1027.Eur.J.Pharmacol.586313PMID:18374912
Keywords:GIT27,supplier,Interfers,TLR4,TLR2/6,signalling,Immunomodulators,reduces,production,pro-inflammatory,cytokines,Toll-like,Receptors,TNF-α,TNF-alpha,Interleukins,Tumor,Necrosis,Factor-α,Factor-alpha,Cytokines,Cytokine,NF-κB,NF-kappaB,Signaling,Signalling,GI,Cytokines,Toll-like,Receptors,Cytokines,TocrisBioscience